Overview
Universal Ibogaine (TSXV:IBO,OTCQB:IBOGF,FSE:JC4) is a Canadian company working to develop the gold standard for addiction treatment.
The company is developing an ibogaine based drug franchise to treat addiction and related mental health issues. These treatments will be administered within a global network of owned and franchised state-of-the-art holistic treatment clinics.
Addiction doesn’t just affect 1 in 5, it affects everyone.
Addiction and the underlying mental health challenges are the true epidemic of our time. No family has not been touched by the problem of addiction. The pointed end of the addiction crisis is opioid related overdose death. Opioid overdose has become the leading cause of accidental death in North America. Approximately 150 people die every day in North America. In Vancouver BC, the center of the opioid problem in Canada, one person dies from opioid overdose every two hours.
Opioids can be found in methamphetamine licit and illicit forms. Several opioid medications, including codeine, fentanyl, morphine, oxycodone and diacetylmorphine are produced and used most often to treat pain. Problematic opioid use generally occurs when a patient finds they are unable to discontinue use upon the completion of their prescription. The patient is then forced to turn to illicit sources.
What is Ibogaine?
Ibogaine is a psychoactive alkaloid extracted from the root bark of Tabernanthe iboga, a Central West African rain forest shrub called iboga. Iboga has been…
